Reviewed by the PeptideMind Team · Updated August 6, 2026

Ipamorelin vs Sermorelin:
Key differences comparison

The main difference between Ipamorelin and Sermorelin is which receptor each one uses to raise growth hormone. Ipamorelin is a selective ghrelin-receptor agonist that produces a sharp, short GH pulse with little effect on cortisol, prolactin, or appetite hormones. Sermorelin is a GHRH analogue that works through a separate receptor to signal the pituitary directly, closer to the body's own nighttime GH rhythm, though it clears the body even faster than Ipamorelin. Because they act on different pathways, the two are frequently combined rather than chosen between.

Growth

ipa

Growth

Ipamorelin

VS

Growth

ser

Growth

Sermorelin

Experimental

WeightGrowth

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

What Is Ipamorelin?

Ipamorelin is a lab-made peptide that mimics ghrelin, the hormone that tells your pituitary gland to release growth hormone. Unlike older peptides in its class, it's built to be selective, meaning it triggers a growth hormone pulse without significantly raising cortisol, prolactin, or hunger hormones the way earlier compounds did.

How it works

Ipamorelin attaches to the ghrelin receptor (GHSR) in the pituitary, producing a short, controlled burst of growth hormone that clears from the body in about 2 hours.

What it's best known for

A clean, selective GH pulse studied for fat metabolism, lean muscle support, sleep quality, and recovery, without the appetite spikes seen with older ghrelin-mimicking peptides.

Where it stands legally

Ipamorelin has no FDA approval for any use. It's sold online as a research chemical, labeled strictly for laboratory research and not for people to use on themselves.

Infographic titled 'What Is Ipamorelin?' on a smartphone screen showing three cards for its studied effects: growth hormone release, recovery and sleep, and body composition.

What Is Sermorelin?

Sermorelin is a lab-made peptide based on the active portion of GHRH, the natural hormone that tells the pituitary to build and release growth hormone. It was originally FDA-approved under the brand name Geref, but that approval was withdrawn in 2009 after the manufacturer stopped selling it, not for safety reasons. Today it's available through compounding pharmacies with a prescription, or sold online as a research chemical.

A different, faster-clearing pathway

Sermorelin binds to the GHRH receptor instead of the ghrelin receptor Ipamorelin uses, and it clears the body in about 12 minutes, even faster than Ipamorelin's roughly 2-hour half-life.

What it's best known for

Supporting the body's natural, pulsatile GH release, most often studied for sleep quality, recovery, and general anti-aging support rather than a single targeted outcome.

Where it stands legally

No longer sold as an FDA-approved finished drug since 2009. It's available through compounding pharmacies with a prescription for off-label adult use, or sold online as a research chemical not intended for human use.

Infographic titled 'What Is Sermorelin?' on a smartphone screen showing cards for GHRH-based peptide, ~12-minute half-life, and known uses: sleep, recovery, and healthy aging support.

Ipamorelin vs Sermorelin at a Glance

A side-by-side look at how Ipamorelin and Sermorelin differ in how they work, how they're dosed, and where each stands legally.

Growth

ipa

Weight

Ipamorelin

Overview

Type
Single peptide
Primary category
Growth
Secondary categories
WeightSleep
Research status
Phase 2
FDA approved
Not FDA approved
Popularity
9/10
Body targets
HormonesMuscle
Price range
$23.99 – $95.00
Human trial status
Human RCTs
Legal status
Research chemical
WADA status
Banned

Dosing

Dose
200–300 mcg
Frequency
5 days on / 2 off
Cycle
12 weeks on / 4 weeks off
Route of administration
Subcutaneous
Common vial sizes
5mg10mg

Research

Molecular weight
711.87 g/mol
Half-life
2 hrs
Median onset
Prescription alternative
Has alternative
Receptor target
GHSR
Receptor action
Agonist
Mechanistic pathways
GH Secretagogue Ghrelin

Growth

ser

Weight

Sermorelin

Experimental

WeightGrowth

Overview

Type
Single peptide
Primary category
Growth
Secondary categories
Weight
Research status
Experimental
FDA approved
Not FDA approved
Popularity
10/10
Body targets
Hormones
Price range
Human trial status
Human RCTs
Legal status
Prescription required
WADA status
Banned

Dosing

Dose
200–500 mcg
Frequency
5 days on / 2 off
Cycle
8–12 weeks on / 4 weeks off
Route of administration
Subcutaneous
Common vial sizes
2mg5mg+1

Research

Molecular weight
3358 g/mol
Half-life
0.2 hrs
Median onset
Prescription alternative
Has alternative
Receptor target
GHRHR
Receptor action
Agonist
Mechanistic pathways
GHRH GH AXIS

Included in

Not part of any blends yet.

Our top-rated vendor

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

Visit site
View all vendors

Comparison at a Glance: Ipamorelin vs Sermorelin

A quick side-by-side look at how Ipamorelin and Sermorelin differ in what receptor they use, how long they last in the body, and where each stands legally.

How each one triggers GH release

Ipamorelin binds to the ghrelin receptor for a sharp, selective GH pulse. Sermorelin binds to the separate GHRH receptor, signaling the pituitary in a pattern closer to the body's own release rhythm.

How long each stays active

Sermorelin clears the body fastest, in about 12 minutes. Ipamorelin lasts noticeably longer, around 2 hours, though both are dosed to work with the body's natural pulsing pattern rather than a constant level.

Selectivity and side effects

Ipamorelin is prized for minimal effect on cortisol, prolactin, and hunger hormones compared to older ghrelin-mimicking peptides. Sermorelin's most reported side effect is mild injection-site irritation, seen in roughly 1 in 6 users in clinical data.

Legal status

Sermorelin's branded version, Geref, was FDA-approved before its 2009 withdrawal, so it's now available through compounding pharmacies with a prescription. Ipamorelin has never been FDA-approved and is sold strictly as a research chemical.

Ipamorelin vs Sermorelin comparison graphic on a smartphone screen showing icons for receptor pathway, duration in the body, side-effect profile, and legal status.

Ipamorelin Dosage Guide for Fat Loss / Muscle

Ipamorelin encourages your body to release its own growth hormone and tends to cause fewer side effects than similar peptides. It's usually injected at night on an empty stomach, since that's when the body's own growth hormone surge happens. Doses above 300 mcg don't produce proportionally more growth hormone, so 300 mcg per injection is the practical ceiling.

Vial size

10 mg

Bacteriostatic water

3 mL

Dosing

200–300 mcg

Frequency

5 days on / 2 off

Cycle

12 weeks on / 4 weeks off

Benefit

Fat Loss / Muscle

Explore calculators

Sermorelin Dosage Guide for Muscle Growth

Sermorelin encourages your body to release more of its own growth hormone. It's injected at night on an empty stomach, 30 to 60 minutes before bed, to line up with the body's natural overnight growth hormone release. Most protocols start at 200 to 300 mcg and increase by about 100 mcg every week or two.

Vial size

5 mg

Bacteriostatic water

3 mL

Dosing

200–500 mcg

Frequency

5 days on / 2 off

Cycle

8–12 weeks on / 4 weeks off

Benefit

Muscle Growth

Explore calculators

Ipamorelin vs Sermorelin: Which One Should You Research?

Because Ipamorelin and Sermorelin act on two different receptors, ghrelin and GHRH, they're commonly studied together rather than as a strict either-or choice. Combining a GHRH analogue with a ghrelin-receptor peptide is one of the most frequently discussed pairings in growth hormone research.

If a selective, well-tolerated GH pulse is the priority

Ipamorelin is reported to raise growth hormone with minimal effect on cortisol, prolactin, or appetite, making it the more targeted single-agent option of the two.

If a prescription pathway or natural rhythm matters more

Sermorelin works through the same receptor pathway your body already uses and remains available through compounding pharmacies with a prescription, unlike Ipamorelin.

Neither is approved for general anti-aging or bodybuilding use

Sermorelin's only FDA approval was on a discontinued branded product, and Ipamorelin has never held one. Research-grade versions of both peptides are sold strictly for research, not for people to use on themselves.

Ipamorelin vs Sermorelin graphic on a phone screen listing research focus areas including weight, metabolic, growth, healing, longevity, cognitive, sexual, and hormonal effects.

Frequently Asked Questions: Ipamorelin vs Sermorelin

Straight answers on how Ipamorelin and Sermorelin compare, and how each is dosed. For research reference only.

Ipamorelin vs Sermorelin: Dosing Basics

Both peptides are typically dosed on a similar weekly pattern, but the amount per injection and the length of a cycle differ between the two.

Ipamorelin dosing

Commonly discussed at 200-300 mcg injected subcutaneously, 5 days on and 2 days off, in cycles of roughly 12 weeks on followed by a 4-week break.

Sermorelin dosing

Commonly discussed at 200-500 mcg injected subcutaneously on the same 5-days-on, 2-days-off pattern, usually before bed, in shorter cycles of about 8-12 weeks on and 4 weeks off.

Use a peptide-specific calculator

How concentrated the vial is and how much liquid you mix in changes the actual draw for both peptides. Use a dosage calculator to get an exact number instead of guessing from a general range.

'Dosing Basics' phone screen graphic comparing Ipamorelin at 200-300 mcg to Sermorelin at 200-500 mcg, with injection site and cycle icons.

What to Expect: Week by Week

Timelines vary by person, dose, and which peptide is used, but research write-ups and clinical data describe a similar general pattern for both.

Weeks 1 to 2

Both peptides begin raising growth hormone within the first dose, with IGF-1 levels typically starting to climb over the first one to two weeks. Mild injection-site reactions or, with Ipamorelin, brief hunger after dosing are sometimes reported early on.

Weeks 3 to 8

Sleep quality and recovery are the most commonly reported early changes with either peptide. Ipamorelin users more often describe changes in body composition and training recovery, while Sermorelin users more often describe steadier sleep and energy improvements.

Weeks 8 to 12 and beyond

Cumulative effects on lean muscle, recovery, and general well-being are typically described as building gradually over a full cycle. Effects from either peptide fade within weeks of stopping, since neither creates a permanent change, and many protocols cycle off for about 4 weeks before resuming.

What to Expect timeline infographic comparing Ipamorelin and Sermorelin on a phone screen listing stages: Weeks 1-2, Weeks 3-8, and Weeks 8-12+.